Immunosuppressive Agents: all 5,940 studies that test it
Page 42 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- "Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"Status unknownNCT01641406Phase 2
- Effect of Different Therapeutic Strategies on Regulatory T Cells in Kidney TransplantationCompletedNCT01640743Not applicable
- THalidomide on Left ventricUlar Morphology aND Function in congEstive heaRt FailureStatus unknownNCT01640639Phase 4
- Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial CancerWithdrawnNCT01639521Phase 2
- A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of ActionCompletedNCT01638715Phase 4
- Thalidomide fOr the Prevention of Restenosis After Coronary ArtERy Stent ImplantationStatus unknownNCT01638078Phase 4
- Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck CancerCompletedNCT01637194Phase 1
- Determination of Intratumoral Concentrations of Kinase Inhibitors in Patients With Advanced Solid Malignancies.CompletedNCT01636908Not applicable
- Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male VolunteersStatus unknownNCT01635686Phase 1
- Methotrexate for Central Serous Chorioretinopathy Treatment TrialStatus unknownNCT01633983Phase 2
- The Vienna RAP Pilot StudyCompletedNCT01632605Not applicable
- Renal Transplantation in the Elderly - nEverOld StudyStatus unknownNCT01631058Phase 4
- Cyclophosphamide Therapy for Refractory Antibody-Mediated Rejection (AMR) in Kidney TransplantsTerminatedNCT01630538Phase 2
- 4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast CancerCompletedNCT01626222Phase 3
- ENGYNE Exploring Gilenya in Patients With Neutralizing Antibodies Against InterferonWithdrawnNCT01621269Phase 4
- Rapamune Improves Outcomes of Severe H1N1 PneumoniaCompletedNCT01620307Phase 2
- An Open-Label, Study to Treat Patients With Renal Allograft and Polyoma BK ViruriaTerminatedNCT01620268Phase 2
- NK Cells in Cord Blood TransplantationStatus unknownNCT01619761Phase 1
- Disease-Modifying Antirheumatic Drugs Cycle Combination Therapy ResearchStatus unknownNCT01617590Not applicable
- A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of TimeCompletedNCT01614665Phase 2
- Efficacy and Safety of Tripterygium Wilfordii in Patients With Rheumatoid ArthritisCompletedNCT01613079Phase 2/3
- Effects of Zortress® + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant RecipientsWithdrawnNCT01612299Not applicable
- Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant ChemotherapyStatus unknownNCT01612247Not applicable
- Leflunomide+Vemurafenib in V600 Mutant Met. MelanomaTerminatedNCT01611675Phase 1
- Study of Everolimus in de Novo Renal Transplant RecipientsTerminatedNCT01609673Not applicable
- A Clinical Trial to Assess the Efficacy and Safety of the Conversion to EverolimusStatus unknownNCT01608412Phase 4
- Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT01606241Phase 1
- Ultrasound and Withdrawal of Biological DMARDs in Rheumatoid ArthritisTerminatedNCT01602302Phase 4
- Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced CancerCompletedNCT01596140Phase 1
- Comparison of Efficacy and Safety of Treatment With a Calcineurin Inhibitor (CNI)Versus a CNI-free Treatment in Renal Transplantation (CIME)CompletedNCT01595984Phase 3
- Cyclosporine A in Cardiac ArrestCompletedNCT01595958Phase 3
- Sirolimus Use in Angioplasty for Vascular Access ExtensionCompletedNCT01595841Phase 2
- A Prospective, Open Label Study of CERtican in KIdney TransplantationCompletedNCT01594268Phase 4
- Study to Evaluate Safety and Immunologic Biomarker of Rapamune in Patients With Stable Renal Transplant RecipientStatus unknownNCT01592253Not applicable
- Proactive Treatment of Tacrolimus Ointment for Adult Facial Seborrheic DermatitisCompletedNCT01591070Phase 4
- Evaluate Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETsCompletedNCT01590199Phase 1
- Safety and Efficacy of Triamcinolone Acetonide Combined With Laser, Bevacizumab Combined With Laser Versus Laser Alone for the Treatment of Diffuse Non-tractional Diabetic Macular EdemaCompletedNCT01572350Phase 3
- Treatment Study of Frozen Shoulder: Corticosteroid Injection in Joint Versus Wait and See PolicyStatus unknownNCT01570985Phase 3
- Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung DiseaseCompletedNCT01570764Phase 3
- Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NETCompletedNCT01567488Phase 2
- The Combination of Rad001 and Rituximab In Patients With Non-hodgkin's LymphomasCompletedNCT01567475Phase 1
- Allogeneic Hematopoietic Stem Cell Transplantation Using a Non-myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-thymocyte Globulin for Older Patients With Relapsed Lymphoid MalignanciesCompletedNCT01566656Phase 2
- A Study to Identify a Biomarker Predictive for Response on Everolimus in Solid Tumors (CPCT-03)CompletedNCT01566279Not applicable
- A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid ArthritisCompletedNCT01565655Phase 2
- Adalimumab on Preventing Post-chirurgic Recurrence on Crohn´s DiseaseCompletedNCT01564823Phase 3
- TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus PerfusionTerminatedNCT01564095Phase 2/3
- Effect of the Inhibition of the Mammalian Target of Rapamycin on Metabolism and ExerciseTerminatedNCT01561404Phase 4
- Efficacy and Safety of Two Regimens of Maintenance Therapy in Children With Crohn DiseaseStatus unknownNCT01559142Phase 3
- A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to MethotrexateCompletedNCT01554696Phase 2
- A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis PatientsCompletedNCT01552629Phase 2
- Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal CancerStatus unknownNCT01551641Phase 2
- Phase 1 Trial of the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus Plus Radiation Therapy (RT) for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following ProstatectomyCompletedNCT01548807Phase 1
- Long-term Efficacy of Iguratimod Alone or Iguratimod in Combination With Methotrexate in Patients With Rheumatoid ArthritisStatus unknownNCT01548001Phase 4
- Tacrolimus Ointment in Oral Lichen PlanusTerminatedNCT01544842Not applicable
- Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By SurgeryCompletedNCT01537107Phase 1
- Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerCompletedNCT01536054Phase 1
- Drug Interaction Study of Isavuconazole and TacrolimusCompletedNCT01535547Phase 1
- Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 YearsStatus unknownNCT01532856Phase 3
- Controlled Level EVERolimus in Acute Coronary SyndromesCompletedNCT01529554Phase 1/2
- Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab Pateinets With Aggresive NHLCompletedNCT01527422Phase 1/2
- Risk-adapted Therapy for Primary Systemic (AL) AmyloidosisCompletedNCT01527032Phase 2
- Phase II Trial Designed to Determine Efficacy and Safety of Bendamustine+Dexamethasone+Thalidomide in R/R MMCompletedNCT01526694Phase 2
- Docetaxel With or Without Metronomic Cyclophosphamide as First Line Chemotherapy in Metastatic Breast CancerStatus unknownNCT01526499Phase 2
- Intratympanic Injection for Autoimmune Inner Ear DiseaseTerminatedNCT01526174Phase 1/2
- Stem Cell Transplantation for Patients With Multiple MyelomaCompletedNCT01526096Phase 1
- Single Arm Study of RAD001 as Monotherapy in Treatment in Advanced CholangiocarcinomaStatus unknownNCT01525719Phase 2
- A Randomized Clinical Trial of the Effect of Pimecrolimus Cream 1% Compared With Topical Corticosteroid in Treatment of Erosive Oral Lichen PlanusStatus unknownNCT01524744Phase 2
- Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALLCompletedNCT01523977Phase 1
- Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk PatientsCompletedNCT01516580Phase 3
- Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab EvaluationCompletedNCT01516567Phase 2
- A Drug-Drug Interaction Study Between Danoprevir/Low-Dose Ritonavir and Cyclosporine in Healthy VolunteersCompletedNCT01514968Phase 1
- Gastric Cancer RAD001 StudyCompletedNCT01514110Phase 1/2
- A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs)CompletedNCT01511003Phase 4
- Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell CarcinomaCompletedNCT01510119Phase 1/2
- PhaseII,Open-label,Pilot Study Evaluating the Safety+Efficacy of Certican ® in the Prevention of Chronic Graft-versus-host Disease+Late Pulmonary Complications After Allogeneic Hematopoietic Cell Transplantation BloodCompletedNCT01509560Phase 2
- HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid TumorsStatus unknownNCT01509300Phase 1/2
- Study to Assess Effect of Cyclosporine on the Blood Levels of TicagrelorCompletedNCT01504906Phase 1
- Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer PatientsStatus unknownNCT01503905Not applicable
- 90 Y-BC8-DOTA Monoclonal Antibody, Fludarabine Phosphate, and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple MyelomaCompletedNCT01503242Phase 1
- Ph I/II Study of Allogeneic SCT for Clinically Aggressive Sickle Cell Disease (SCD)Active, not recruitingNCT01499888Phase 1/2
- Belatacept in Renal Transplantation With Intermediate Risk Maryland Aggregate Pathology Index (MAPI) ScoresCompletedNCT01496417Not applicable
- Drug Interaction Study of Isavuconazole and CyclosporineCompletedNCT01494597Phase 1
- Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer PatientsTerminatedNCT01493154Phase 1
- Kidney Allograft Dysfunction Without Reversible CausesWithdrawnNCT01492894Phase 4
- Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose ReductionStatus unknownNCT01491815Phase 4
- Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal CancerCompletedNCT01490749Phase 1
- Efficacy and Safety Study of RAD001 in the Growth of the Vestibular Schwannoma(s) in Neurofibromatosis 2 (NF2) PatientsCompletedNCT01490476Phase 2
- Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry EyeCompletedNCT01488396Phase 4
- Sirolimus/Tacrolimus Combination After HLA Matched Related Peripheral Blood Stem Cell TransplantsTerminatedNCT01488253Phase 2
- Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With RelapsesCompletedNCT01487096Phase 2
- A Single Oral Dose Study of ASP015K in Healthy Volunteers Assessing the Relative Bioavailability Across Three Tablet Strengths From a New Formulation of ASP015KCompletedNCT01486017Phase 1
- Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic TelangiectasiaCompletedNCT01485224Phase 2
- A Single Oral Dose Study to Compare the Bioavailability Between Two Different Tablet Formulations and Assess if There is a Food Effect With the New FormulationCompletedNCT01484964Phase 1
- RAD001 in Advanced Gastric Cancer Who Failed Standard First-line Treatment With pS6 Ser 240/4 ExpressionCompletedNCT01482299Phase 2
- Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid TumorsCompletedNCT01482156Phase 1
- ACVDL Treatment for Patients With Newly Diagnosed Multiple MyelomaCompletedNCT01481194Phase 2
- A Study in Healthy Participants Investigating the Effect of TMC435 on the Pharmacokinetics of Immunosuppressants Cyclosporine and TacrolimusCompletedNCT01479881Phase 1
- Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By SurgeryCompletedNCT01477021Phase 1
- Evaluation of Efficacy and Tolerance of Cladribine in Symptomatic Pulmonary Langerhans Cell HistiocytosisStatus unknownNCT01473797Phase 2
- ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast CancerCompletedNCT01472146Phase 2